Loading
LB
Lexington Biosciences, Inc. (formerly, Glenwood Acquisitions Corp.) Stock: price and insider trades · Canada
Lexington Biosciences, Inc. (formerly, Glenwood Acquisitions Corp.): what insiders have been doing
This page follows insider dealings at Lexington Biosciences, Inc. (formerly, Glenwood Acquisitions Corp.) as filed with SEDI. Nothing new has been filed by managers of Lexington Biosciences, Inc. (formerly, Glenwood Acquisitions Corp.) in twelve months, the latest record being from 4 March 2019.
Since 2017, the database holds 6 purchases and no sales by insiders of the company.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
9
Thresholds
n/a
Buy Volume
€15,364
6 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 4 March 2019
Declarations9 total
20,000 shares@ CA$0.2951.3% of flowCommon SharesTSXSEDI:3327494
Canonical exit: 8 Aug 2018 (T+90)
20,000 shares@ CA$0.2848.7% of flowCommon SharesTSXSEDI:3327499
Canonical exit: 19 Sept 2018 (T+90)
60,000 sharesCommon SharesTSXSEDI:3327460
Canonical exit: 26 Sept 2018 (T+90)
15,000 sharesCommon SharesTSXSEDI:3327464
Canonical exit: 29 Dec 2018 (T+90)
41,500 sharesCommon SharesTSXSEDI:3327458
Canonical exit: 20 Aug 2018 (T+90)
60,000 shares@ CA$0.20Common SharesTSXSEDI:3327495
Canonical exit: 6 Sept 2017 (T+90)
Common SharesTSXSEDI:3327446
Common SharesTSXSEDI:3327432
Common SharesTSXSEDI:2948562
9 of 9 declarations
About Lexington Biosciences, Inc. (formerly, Glenwood Acquisitions Corp.)
Lexington Biosciences, Inc. is a company focused on developing diagnostic technologies for cardiovascular health. Formerly known as Glenwood Acquisitions Corp., it is listed on the XTSE.
